Incremental value of perfusion over wall-motion abnormalities with the use of dobutamine-atropine stress myocardial contrast echocardiography and magnetic resonance imaging for detecting coronary artery disease

Echocardiography

Volumn 30, Issue 1, 2013, Pages 45-54

  Falcão, Sandra Nivea Dos Reis Saraiva ^a   Rochitte, Carlos Eduardo ^a   Junior, Wilson Mathias ^a   Quaglia, Luiz ^a   Lemos, Pedro Alves ^a   Sbano, João César Nunes ^a   Ramires, José Antonio Franchini ^a   Filho, Roberto Kalil ^a   Tsutsui, Jeane Mike ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fleury   (Brazil)

Author keywords

cardiovascular magnetic resonance; coronary artery disease; myocardial contrast echocardiography; stress test

Indexed keywords

ATROPINE; DOBUTAMINE; GADOTERATE MEGLUMINE; PERFLUTREN;

ADULT; ANALYTIC METHOD; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEGENERATIVE CALCIFIC AORTIC STENOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG MEGADOSE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MICROBUBBLE; MYOCARDIAL PERFUSION IMAGING; MYOCARDIAL PERFUSION OVER WALL MOTION ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; ULTRASOUND SCANNER;

ATROPINE; CARDIOTONIC AGENTS; CONTRAST MEDIA; CORONARY ARTERY DISEASE; DOBUTAMINE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE;

EID: 84872113162     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2012.01820.x     Document Type: Article

References (35)

1. Geleijnse ML, Fioretti PM, Roelandt JR,: Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 1997; 30: 595-606.
2. Picano E, Mathias W, Jr., Pingitore A, et al. Safety and tolerability of dobutamine-atropine stress echocardiography: A prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet 1994; 344: 1190-1192.
3. Mathias W, Jr., Arruda A, Santos FC, et al. Safety of dobutamine-atropine stress echocardiography: A prospective experience of 4,033 consecutive studies. J Am Soc Echocardiogr 1999; 12: 785-791.
4. Secknus MA, Marwick TH,: Evolution of dobutamine echocardiography protocols and indications: Safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol 1997; 29: 1234-1240.
5. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress CMR: Comparison with dobutamine stress echocardiography. Circulation 1999; 99: 763-770.
6. Paetsch I, Jahnke C, Wahl A, et al. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 2004; 110: 835-842.
7. Tsutsui JM, Elhendy A, Xie F, et al. Safety of dobutamine stress real-time myocardial contrast echocardiography. J Am Coll Cardiol 2005; 45: 1235-1242.
8. Elhendy A, O'leary EL, Xie F, et al. Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol 2004; 44: 2185-2191.
9. Tsutsui JM, Elhendy A, Anderson JR, et al. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation 2005; 112: 1444-1450.
10. Lubbers DD, Janssen CH, Kuijpers D, et al. The additional value of first pass myocardial perfusion imaging during peak dose of dobutamine stress cardiac CMR for the detection of myocardial ischemia. Int J Cardiovasc Imaging 2008; 24: 69-76.
11. Mandapaka S, Hundley WG,: Dobutamine cardiovascular magnetic resonance: A review. J Magn Reson Imaging 2006; 24: 499-512.
12. Kelle S, Hamdan A, Schnackenburg B, et al. Dobutamine stress cardiovascular magnetic resonance at 3 Tesla. J Cardiovasc Magn Reson 2008; 10: 44.
13. Kramer CM, Barkhausen J, Flamm SD, et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: Board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 2008; 10: 35.
14. Armstrong WF, Zoghbi WA,: Stress echocardiography: Current methodology and clinical applications. J Am Coll Cardiol 2005; 45: 1739-1747.
15. Tsutsui JM, Lario FC, Fernandes DR, et al. Safety and cardiac chronotropic responsiveness to the early injection of atropine during dobutamine stress echocardiography in the elderly. Heart 2005; 91: 1563-1567.
16. Tsutsui JM, Osorio AF, Lario FA, et al. Comparison of safety and efficacy of the early injection of atropine during dobutamine stress echocardiography with the conventional protocol. Am J Cardiol 2004; 94: 1367-1372.
17. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
18. Cerqueira MD, Weissman NJ, Dilsizian V, et al. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539-542.
19. Gebker R, Jahnke C, Manka R, et al. Additional value of myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of coronary artery disease. Circ Cardiovasc Imaging 2008; 1: 122-130.
20. Bin JP, Pelberg RA, Wei K, et al. Dobutamine versus dipyridamole for inducing reversible perfusion defects in chronic multivessel coronary artery stenosis. J Am Coll Cardiol 2002; 40: 167-174.
21. Lewandowski TJ, Armstrong WF, Bach DS,: Reduced test time by early identification of patients requiring atropine during dobutamine stress echocardiography. J Am Soc Echocardiogr 1998; 11: 236-242.
22. Tsutsui JM, Falcao SN, Dourado PM, et al. Gender differences in chronotropic and hemodynamic responses during dobutamine-atropine stress echocardiography. Echocardiography 2007; 24: 843-850.
23. Tsutsui JM, Dourado PM, Falcao SN, et al. Prognostic value of dobutamine stress echocardiography with early injection of atropine with versus without chronic beta-blocker therapy in patients with known or suspected coronary heart disease. Am J Cardiol 2008; 102: 1291-1295.
24. Nagel E, Lorenz C, Baer F, et al. Stress cardiovascular magnetic resonance: Consensus panel report. J Cardiovasc Magn Reson 2001; 3: 267-281.
25. Nesto RW, Kowalchuk GJ,: The ischemic cascade: Temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 1987; 59: 23C-30C.
26. Kaul S, Senior R, Dittrich H, et al. Detection of coronary artery disease with myocardial contrast echocardiography: Comparison with 99mTc-sestamibi single-photon emission computed tomography. Circulation 1997; 96: 785-792.
27. Nagel E, Al-Saadi N, Fleck E,: Cardiovascular magnetic resonance: Myocardial perfusion. Herz 2000; 25: 409-416.
28. Mulvagh SL, Rakowski H, Vannan MA, et al. American Society of Echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography. J Am Soc Echocardiogr 2008; 21: 1179-1201.
29. Leong-Poi H, Rim SJ, Le DE, et al. Perfusion versus function: The ischemic cascade in demand ischemia: Implications of single-vessel versus multivessel stenosis. Circulation 2002; 105: 987-992.
30. Tsutsui JM, Xie F, Cloutier D, et al. Real-time dobutamine stress myocardial perfusion echocardiography predicts outcome in the elderly. Eur Heart J 2008; 29: 377-385.
31. Dijkmans PA, Senior R, Becher H, et al. Myocardial contrast echocardiography evolving as a clinically feasible technique for accurate, rapid, and safe assessment of myocardial perfusion: The evidence so far. J Am Coll Cardiol 2006; 48: 2168-2177.
32. Parisi AF, Hartigan PM, Folland ED,: Evaluation of exercise thallium scintigraphy versus exercise electrocardiography in predicting survival outcomes and morbid cardiac events in patients with single- and double-vessel disease. Findings from the Angioplasty Compared to Medicine (ACME) Study. J Am Coll Cardiol 1997; 30: 1256-1263.
33. Pennell DJ, Sechtem UP, Higgins CB, et al. European Society of cardiology. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. J Cardiovasc Magn Reson 2004; 6: 727-765.
34. Hundley WG, Hamilton CA, Thomas MS, et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 1999; 100: 1697-1702.
35. Wahl A, Paetsch I, Gollesch A, et al. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischaemia: Experience in 1000 consecutive cases. Eur Heart J 2004; 25: 1230-1236.